| 000 | 01864 a2200541 4500 | ||
|---|---|---|---|
| 005 | 20250517215257.0 | ||
| 264 | 0 | _c20181106 | |
| 008 | 201811s 0 0 eng d | ||
| 022 | _a1873-2496 | ||
| 024 | 7 |
_a10.1016/j.urolonc.2018.04.008 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aTeishima, Jun | |
| 245 | 0 | 0 |
_aNormalization of C-reactive protein levels following cytoreductive nephrectomy in patients with metastatic renal cell carcinoma treated with tyrosine kinase inhibitors is associated with improved overall survival. _h[electronic resource] |
| 260 |
_bUrologic oncology _cJul 2018 |
||
| 300 |
_a339.e9-339.e15 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article | ||
| 650 | 0 | 4 | _aAdult |
| 650 | 0 | 4 | _aAged |
| 650 | 0 | 4 | _aAged, 80 and over |
| 650 | 0 | 4 |
_aBiomarkers, Tumor _xblood |
| 650 | 0 | 4 |
_aC-Reactive Protein _xanalysis |
| 650 | 0 | 4 |
_aCarcinoma, Renal Cell _xblood |
| 650 | 0 | 4 |
_aCytoreduction Surgical Procedures _xmortality |
| 650 | 0 | 4 | _aFemale |
| 650 | 0 | 4 | _aFollow-Up Studies |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 |
_aKidney Neoplasms _xblood |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 | _aMiddle Aged |
| 650 | 0 | 4 | _aMolecular Targeted Therapy |
| 650 | 0 | 4 | _aNeoplasm Invasiveness |
| 650 | 0 | 4 | _aNeoplasm Metastasis |
| 650 | 0 | 4 |
_aNephrectomy _xmortality |
| 650 | 0 | 4 | _aPrognosis |
| 650 | 0 | 4 |
_aProtein Kinase Inhibitors _xtherapeutic use |
| 650 | 0 | 4 | _aRetrospective Studies |
| 650 | 0 | 4 | _aSurvival Rate |
| 700 | 1 | _aOhara, Shinya | |
| 700 | 1 | _aShinmei, Shunsuke | |
| 700 | 1 | _aInoue, Shogo | |
| 700 | 1 | _aHayashi, Tetsutaro | |
| 700 | 1 | _aMochizuki, Hideki | |
| 700 | 1 | _aMita, Koji | |
| 700 | 1 | _aShigeta, Masanobu | |
| 700 | 1 | _aMatsubara, Akio | |
| 773 | 0 |
_tUrologic oncology _gvol. 36 _gno. 7 _gp. 339.e9-339.e15 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1016/j.urolonc.2018.04.008 _zAvailable from publisher's website |
| 999 |
_c28403179 _d28403179 |
||